ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Valbenazine API Market Research Report 2026
Published Date: 2026-02-04
|
Report Code: QYRE-Auto-16I18532
Home | Market Reports
Global Valbenazine API Market Research Report 2024
BUY CHAPTERS

Global Valbenazine API Market Research Report 2026

Code: QYRE-Auto-16I18532
Report
2026-02-04
Pages:113
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
MSN Laboratories
SynZeal research
Lupin Ltd
Jiangxi Longlife Bio-pharmaceutical
Jiangsu Vcare PharmaTech
Nantong HI-FUTURE Biology
Shaanxi Dideu Medichem
Acharya Chemical
Chengdu Miracle Pharmaceutical
Zhejiang Hengtengfu Pharmaceutical

Valbenazine API Market

The global Valbenazine API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Valbenazine API competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Valbenazine is an active pharmaceutical ingredient (API) used in the treatment of tardive dyskinesia, commonly available in oral capsule form. As a selective vesicular monoamine transporter 2 (VMAT2) inhibitor, valbenazine functions by modulating the release of neurotransmitters such as dopamine, ultimately reducing the severity of abnormal movements associated with the condition.
The North American market for Valbenazine API is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Valbenazine API is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Valbenazine API include MSN Laboratories, SynZeal Research, Lupin, Acharya Chemical, Jiangxi LongLife Bio-pharmaceutical, Chengdu Miracle Pharmaceutical, Zhejiang Hengtengfu Pharmaceutical, Jiangsu Vcare PharmaTech, Nantong HI-FUTURE Biology, Shaanxi Dideu Medichem, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Valbenazine API market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Valbenazine API. The Valbenazine API market size, estimates, and forecasts are provided in terms of sales volume (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Valbenazine API market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Valbenazine API manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Valbenazine API Market Report

Report Metric Details
Report Name Valbenazine API Market
Segment by Type
  • Purity ≥ 98%
  • Purity ≥ 99%
by Application
  • Online Sales
  • Offline Sales
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company MSN Laboratories, SynZeal Research, Lupin, Acharya Chemical, Jiangxi LongLife Bio-pharmaceutical, Chengdu Miracle Pharmaceutical, Zhejiang Hengtengfu Pharmaceutical, Jiangsu Vcare PharmaTech, Nantong HI-FUTURE Biology, Shaanxi Dideu Medichem
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Valbenazine API manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Valbenazine API sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Valbenazine API Market report?

Ans: The main players in the Valbenazine API Market are MSN Laboratories, SynZeal Research, Lupin, Acharya Chemical, Jiangxi LongLife Bio-pharmaceutical, Chengdu Miracle Pharmaceutical, Zhejiang Hengtengfu Pharmaceutical, Jiangsu Vcare PharmaTech, Nantong HI-FUTURE Biology, Shaanxi Dideu Medichem

What are the Application segmentation covered in the Valbenazine API Market report?

Ans: The Applications covered in the Valbenazine API Market report are Online Sales, Offline Sales

What are the Type segmentation covered in the Valbenazine API Market report?

Ans: The Types covered in the Valbenazine API Market report are Purity ≥ 98%, Purity ≥ 99%

1 Valbenazine API Market Overview
1.1 Product Definition
1.2 Valbenazine API by Type
1.2.1 Global Valbenazine API Market Value by Type: 2025 vs 2032
1.2.2 Purity ≥ 98%
1.2.3 Purity ≥ 99%
1.3 Valbenazine API by Application
1.3.1 Global Valbenazine API Market Value by Application: 2025 vs 2032
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Global Valbenazine API Market Size Estimates and Forecasts
1.4.1 Global Valbenazine API Revenue 2021–2032
1.4.2 Global Valbenazine API Sales 2021–2032
1.4.3 Global Valbenazine API Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Valbenazine API Market Competition by Manufacturers
2.1 Global Valbenazine API Sales Market Share by Manufacturers (2021–2026)
2.2 Global Valbenazine API Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Valbenazine API Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Valbenazine API, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Valbenazine API, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Valbenazine API, Product Types and Applications
2.7 Global Key Manufacturers of Valbenazine API, Date of Entry into the Industry
2.8 Global Valbenazine API Market Competitive Situation and Trends
2.8.1 Global Valbenazine API Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Valbenazine API Players Market Share by Revenue
2.8.3 Global Valbenazine API Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Valbenazine API Market Scenario by Region
3.1 Global Valbenazine API Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Valbenazine API Sales by Region: 2021–2032
3.2.1 Global Valbenazine API Sales by Region: 2021–2026
3.2.2 Global Valbenazine API Sales by Region: 2027–2032
3.3 Global Valbenazine API Revenue by Region: 2021–2032
3.3.1 Global Valbenazine API Revenue by Region: 2021–2026
3.3.2 Global Valbenazine API Revenue by Region: 2027–2032
3.4 North America Valbenazine API Market Facts & Figures by Country
3.4.1 North America Valbenazine API Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Valbenazine API Sales by Country (2021–2032)
3.4.3 North America Valbenazine API Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Valbenazine API Market Facts & Figures by Country
3.5.1 Europe Valbenazine API Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Valbenazine API Sales by Country (2021–2032)
3.5.3 Europe Valbenazine API Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Valbenazine API Market Facts & Figures by Region
3.6.1 Asia Pacific Valbenazine API Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Valbenazine API Sales by Region (2021–2032)
3.6.3 Asia Pacific Valbenazine API Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Valbenazine API Market Facts & Figures by Country
3.7.1 Latin America Valbenazine API Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Valbenazine API Sales by Country (2021–2032)
3.7.3 Latin America Valbenazine API Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Valbenazine API Market Facts & Figures by Country
3.8.1 Middle East and Africa Valbenazine API Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Valbenazine API Sales by Country (2021–2032)
3.8.3 Middle East and Africa Valbenazine API Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Valbenazine API Sales by Type (2021–2032)
4.1.1 Global Valbenazine API Sales by Type (2021–2026)
4.1.2 Global Valbenazine API Sales by Type (2027–2032)
4.1.3 Global Valbenazine API Sales Market Share by Type (2021–2032)
4.2 Global Valbenazine API Revenue by Type (2021–2032)
4.2.1 Global Valbenazine API Revenue by Type (2021–2026)
4.2.2 Global Valbenazine API Revenue by Type (2027–2032)
4.2.3 Global Valbenazine API Revenue Market Share by Type (2021–2032)
4.3 Global Valbenazine API Price by Type (2021–2032)
5 Segment by Application
5.1 Global Valbenazine API Sales by Application (2021–2032)
5.1.1 Global Valbenazine API Sales by Application (2021–2026)
5.1.2 Global Valbenazine API Sales by Application (2027–2032)
5.1.3 Global Valbenazine API Sales Market Share by Application (2021–2032)
5.2 Global Valbenazine API Revenue by Application (2021–2032)
5.2.1 Global Valbenazine API Revenue by Application (2021–2026)
5.2.2 Global Valbenazine API Revenue by Application (2027–2032)
5.2.3 Global Valbenazine API Revenue Market Share by Application (2021–2032)
5.3 Global Valbenazine API Price by Application (2021–2032)
6 Key Companies Profiled
6.1 MSN Laboratories
6.1.1 MSN Laboratories Company Information
6.1.2 MSN Laboratories Description and Business Overview
6.1.3 MSN Laboratories Valbenazine API Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 MSN Laboratories Valbenazine API Product Portfolio
6.1.5 MSN Laboratories Recent Developments/Updates
6.2 SynZeal Research
6.2.1 SynZeal Research Company Information
6.2.2 SynZeal Research Description and Business Overview
6.2.3 SynZeal Research Valbenazine API Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 SynZeal Research Valbenazine API Product Portfolio
6.2.5 SynZeal Research Recent Developments/Updates
6.3 Lupin
6.3.1 Lupin Company Information
6.3.2 Lupin Description and Business Overview
6.3.3 Lupin Valbenazine API Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Lupin Valbenazine API Product Portfolio
6.3.5 Lupin Recent Developments/Updates
6.4 Acharya Chemical
6.4.1 Acharya Chemical Company Information
6.4.2 Acharya Chemical Description and Business Overview
6.4.3 Acharya Chemical Valbenazine API Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Acharya Chemical Valbenazine API Product Portfolio
6.4.5 Acharya Chemical Recent Developments/Updates
6.5 Jiangxi LongLife Bio-pharmaceutical
6.5.1 Jiangxi LongLife Bio-pharmaceutical Company Information
6.5.2 Jiangxi LongLife Bio-pharmaceutical Description and Business Overview
6.5.3 Jiangxi LongLife Bio-pharmaceutical Valbenazine API Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Jiangxi LongLife Bio-pharmaceutical Valbenazine API Product Portfolio
6.5.5 Jiangxi LongLife Bio-pharmaceutical Recent Developments/Updates
6.6 Chengdu Miracle Pharmaceutical
6.6.1 Chengdu Miracle Pharmaceutical Company Information
6.6.2 Chengdu Miracle Pharmaceutical Description and Business Overview
6.6.3 Chengdu Miracle Pharmaceutical Valbenazine API Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Chengdu Miracle Pharmaceutical Valbenazine API Product Portfolio
6.6.5 Chengdu Miracle Pharmaceutical Recent Developments/Updates
6.7 Zhejiang Hengtengfu Pharmaceutical
6.7.1 Zhejiang Hengtengfu Pharmaceutical Company Information
6.7.2 Zhejiang Hengtengfu Pharmaceutical Description and Business Overview
6.7.3 Zhejiang Hengtengfu Pharmaceutical Valbenazine API Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Zhejiang Hengtengfu Pharmaceutical Valbenazine API Product Portfolio
6.7.5 Zhejiang Hengtengfu Pharmaceutical Recent Developments/Updates
6.8 Jiangsu Vcare PharmaTech
6.8.1 Jiangsu Vcare PharmaTech Company Information
6.8.2 Jiangsu Vcare PharmaTech Description and Business Overview
6.8.3 Jiangsu Vcare PharmaTech Valbenazine API Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Jiangsu Vcare PharmaTech Valbenazine API Product Portfolio
6.8.5 Jiangsu Vcare PharmaTech Recent Developments/Updates
6.9 Nantong HI-FUTURE Biology
6.9.1 Nantong HI-FUTURE Biology Company Information
6.9.2 Nantong HI-FUTURE Biology Description and Business Overview
6.9.3 Nantong HI-FUTURE Biology Valbenazine API Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Nantong HI-FUTURE Biology Valbenazine API Product Portfolio
6.9.5 Nantong HI-FUTURE Biology Recent Developments/Updates
6.10 Shaanxi Dideu Medichem
6.10.1 Shaanxi Dideu Medichem Company Information
6.10.2 Shaanxi Dideu Medichem Description and Business Overview
6.10.3 Shaanxi Dideu Medichem Valbenazine API Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Shaanxi Dideu Medichem Valbenazine API Product Portfolio
6.10.5 Shaanxi Dideu Medichem Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Valbenazine API Industry Chain Analysis
7.2 Valbenazine API Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Valbenazine API Production Mode & Process Analysis
7.4 Valbenazine API Sales and Marketing
7.4.1 Valbenazine API Sales Channels
7.4.2 Valbenazine API Distributors
7.5 Valbenazine API Customer Analysis
8 Valbenazine API Market Dynamics
8.1 Valbenazine API Industry Trends
8.2 Valbenazine API Market Drivers
8.3 Valbenazine API Market Challenges
8.4 Valbenazine API Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
MSN Laboratories
SynZeal research
Lupin Ltd
Jiangxi Longlife Bio-pharmaceutical
Jiangsu Vcare PharmaTech
Nantong HI-FUTURE Biology
Shaanxi Dideu Medichem
Acharya Chemical
Chengdu Miracle Pharmaceutical
Zhejiang Hengtengfu Pharmaceutical
List of Tables
 Table 1. Global Valbenazine API Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Valbenazine API Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Valbenazine API Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Valbenazine API Sales (Tons) of Key Manufacturers (2021–2026)
 Table 5. Global Valbenazine API Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Valbenazine API Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Valbenazine API Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Valbenazine API Average Price (US$/kg) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Valbenazine API, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Valbenazine API, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Valbenazine API, Product Types and Applications
 Table 12. Global Key Manufacturers of Valbenazine API, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Valbenazine API Companies by Tier (Tier 1, Tier 2, Tier 3), based on Valbenazine API Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Valbenazine API Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Valbenazine API Sales by Region (Tons), 2021–2026
 Table 18. Global Valbenazine API Sales Market Share by Region (2021–2026)
 Table 19. Global Valbenazine API Sales by Region (Tons), 2027–2032
 Table 20. Global Valbenazine API Sales Market Share by Region (2027–2032)
 Table 21. Global Valbenazine API Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Valbenazine API Revenue Market Share by Region (2021–2026)
 Table 23. Global Valbenazine API Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Valbenazine API Revenue Market Share by Region (2027–2032)
 Table 25. North America Valbenazine API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Valbenazine API Sales by Country (Tons), 2021–2026
 Table 27. North America Valbenazine API Sales by Country (Tons), 2027–2032
 Table 28. North America Valbenazine API Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Valbenazine API Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Valbenazine API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Valbenazine API Sales by Country (Tons), 2021–2026
 Table 32. Europe Valbenazine API Sales by Country (Tons), 2027–2032
 Table 33. Europe Valbenazine API Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Valbenazine API Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Valbenazine API Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Valbenazine API Sales by Region (Tons), 2021–2026
 Table 37. Asia Pacific Valbenazine API Sales by Region (Tons), 2027–2032
 Table 38. Asia Pacific Valbenazine API Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Valbenazine API Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Valbenazine API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Valbenazine API Sales by Country (Tons), 2021–2026
 Table 42. Latin America Valbenazine API Sales by Country (Tons), 2027–2032
 Table 43. Latin America Valbenazine API Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Valbenazine API Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Valbenazine API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Valbenazine API Sales by Country (Tons), 2021–2026
 Table 47. Middle East and Africa Valbenazine API Sales by Country (Tons), 2027–2032
 Table 48. Middle East and Africa Valbenazine API Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Valbenazine API Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Valbenazine API Sales (Tons) by Type (2021–2026)
 Table 51. Global Valbenazine API Sales (Tons) by Type (2027–2032)
 Table 52. Global Valbenazine API Sales Market Share by Type (2021–2026)
 Table 53. Global Valbenazine API Sales Market Share by Type (2027–2032)
 Table 54. Global Valbenazine API Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Valbenazine API Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Valbenazine API Revenue Market Share by Type (2021–2026)
 Table 57. Global Valbenazine API Revenue Market Share by Type (2027–2032)
 Table 58. Global Valbenazine API Price (US$/kg) by Type (2021–2026)
 Table 59. Global Valbenazine API Price (US$/kg) by Type (2027–2032)
 Table 60. Global Valbenazine API Sales (Tons) by Application (2021–2026)
 Table 61. Global Valbenazine API Sales (Tons) by Application (2027–2032)
 Table 62. Global Valbenazine API Sales Market Share by Application (2021–2026)
 Table 63. Global Valbenazine API Sales Market Share by Application (2027–2032)
 Table 64. Global Valbenazine API Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Valbenazine API Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Valbenazine API Revenue Market Share by Application (2021–2026)
 Table 67. Global Valbenazine API Revenue Market Share by Application (2027–2032)
 Table 68. Global Valbenazine API Price (US$/kg) by Application (2021–2026)
 Table 69. Global Valbenazine API Price (US$/kg) by Application (2027–2032)
 Table 70. MSN Laboratories Company Information
 Table 71. MSN Laboratories Description and Business Overview
 Table 72. MSN Laboratories Valbenazine API Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 73. MSN Laboratories Valbenazine API Product
 Table 74. MSN Laboratories Recent Developments/Updates
 Table 75. SynZeal Research Company Information
 Table 76. SynZeal Research Description and Business Overview
 Table 77. SynZeal Research Valbenazine API Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 78. SynZeal Research Valbenazine API Product
 Table 79. SynZeal Research Recent Developments/Updates
 Table 80. Lupin Company Information
 Table 81. Lupin Description and Business Overview
 Table 82. Lupin Valbenazine API Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 83. Lupin Valbenazine API Product
 Table 84. Lupin Recent Developments/Updates
 Table 85. Acharya Chemical Company Information
 Table 86. Acharya Chemical Description and Business Overview
 Table 87. Acharya Chemical Valbenazine API Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 88. Acharya Chemical Valbenazine API Product
 Table 89. Acharya Chemical Recent Developments/Updates
 Table 90. Jiangxi LongLife Bio-pharmaceutical Company Information
 Table 91. Jiangxi LongLife Bio-pharmaceutical Description and Business Overview
 Table 92. Jiangxi LongLife Bio-pharmaceutical Valbenazine API Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 93. Jiangxi LongLife Bio-pharmaceutical Valbenazine API Product
 Table 94. Jiangxi LongLife Bio-pharmaceutical Recent Developments/Updates
 Table 95. Chengdu Miracle Pharmaceutical Company Information
 Table 96. Chengdu Miracle Pharmaceutical Description and Business Overview
 Table 97. Chengdu Miracle Pharmaceutical Valbenazine API Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 98. Chengdu Miracle Pharmaceutical Valbenazine API Product
 Table 99. Chengdu Miracle Pharmaceutical Recent Developments/Updates
 Table 100. Zhejiang Hengtengfu Pharmaceutical Company Information
 Table 101. Zhejiang Hengtengfu Pharmaceutical Description and Business Overview
 Table 102. Zhejiang Hengtengfu Pharmaceutical Valbenazine API Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 103. Zhejiang Hengtengfu Pharmaceutical Valbenazine API Product
 Table 104. Zhejiang Hengtengfu Pharmaceutical Recent Developments/Updates
 Table 105. Jiangsu Vcare PharmaTech Company Information
 Table 106. Jiangsu Vcare PharmaTech Description and Business Overview
 Table 107. Jiangsu Vcare PharmaTech Valbenazine API Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 108. Jiangsu Vcare PharmaTech Valbenazine API Product
 Table 109. Jiangsu Vcare PharmaTech Recent Developments/Updates
 Table 110. Nantong HI-FUTURE Biology Company Information
 Table 111. Nantong HI-FUTURE Biology Description and Business Overview
 Table 112. Nantong HI-FUTURE Biology Valbenazine API Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 113. Nantong HI-FUTURE Biology Valbenazine API Product
 Table 114. Nantong HI-FUTURE Biology Recent Developments/Updates
 Table 115. Shaanxi Dideu Medichem Company Information
 Table 116. Shaanxi Dideu Medichem Description and Business Overview
 Table 117. Shaanxi Dideu Medichem Valbenazine API Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 118. Shaanxi Dideu Medichem Valbenazine API Product
 Table 119. Shaanxi Dideu Medichem Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Valbenazine API Distributors List
 Table 123. Valbenazine API Customers List
 Table 124. Valbenazine API Market Trends
 Table 125. Valbenazine API Market Drivers
 Table 126. Valbenazine API Market Challenges
 Table 127. Valbenazine API Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Valbenazine API
 Figure 2. Global Valbenazine API Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Valbenazine API Market Share by Type: 2025 & 2032
 Figure 4. Purity ≥ 98% Product Picture
 Figure 5. Purity ≥ 99% Product Picture
 Figure 6. Global Valbenazine API Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Valbenazine API Market Share by Application: 2025 & 2032
 Figure 8. Online Sales
 Figure 9. Offline Sales
 Figure 10. Global Valbenazine API Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 11. Global Valbenazine API Market Size (US$ Million), 2021–2032
 Figure 12. Global Valbenazine API Sales (Tons), 2021–2032
 Figure 13. Global Valbenazine API Average Price (US$/kg), 2021–2032
 Figure 14. Valbenazine API Report Years Considered
 Figure 15. Valbenazine API Sales Share by Manufacturers in 2025
 Figure 16. Global Valbenazine API Revenue Share by Manufacturers in 2025
 Figure 17. Top 5 and Top 10 Global Valbenazine API Players: Market Share by Revenue in Valbenazine API in 2025
 Figure 18. Valbenazine API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 19. Global Valbenazine API Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 20. North America Valbenazine API Sales Market Share by Country (2021–2032)
 Figure 21. North America Valbenazine API Revenue Market Share by Country (2021–2032)
 Figure 22. United States Valbenazine API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 23. Canada Valbenazine API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Europe Valbenazine API Sales Market Share by Country (2021–2032)
 Figure 25. Europe Valbenazine API Revenue Market Share by Country (2021–2032)
 Figure 26. Germany Valbenazine API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. France Valbenazine API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. U.K. Valbenazine API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Italy Valbenazine API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Russia Valbenazine API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Asia Pacific Valbenazine API Sales Market Share by Region (2021–2032)
 Figure 32. Asia Pacific Valbenazine API Revenue Market Share by Region (2021–2032)
 Figure 33. China Valbenazine API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Japan Valbenazine API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. South Korea Valbenazine API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. India Valbenazine API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Australia Valbenazine API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. China Taiwan Valbenazine API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Southeast Asia Valbenazine API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Latin America Valbenazine API Sales Market Share by Country (2021–2032)
 Figure 41. Latin America Valbenazine API Revenue Market Share by Country (2021–2032)
 Figure 42. Mexico Valbenazine API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Brazil Valbenazine API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Argentina Valbenazine API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Colombia Valbenazine API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Middle East and Africa Valbenazine API Sales Market Share by Country (2021–2032)
 Figure 47. Middle East and Africa Valbenazine API Revenue Market Share by Country (2021–2032)
 Figure 48. Turkey Valbenazine API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Saudi Arabia Valbenazine API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. UAE Valbenazine API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Global Sales Market Share of Valbenazine API by Type (2021–2032)
 Figure 52. Global Revenue Market Share of Valbenazine API by Type (2021–2032)
 Figure 53. Global Valbenazine API Price (US$/kg) by Type (2021–2032)
 Figure 54. Global Sales Market Share of Valbenazine API by Application (2021–2032)
 Figure 55. Global Revenue Market Share of Valbenazine API by Application (2021–2032)
 Figure 56. Global Valbenazine API Price (US$/kg) by Application (2021–2032)
 Figure 57. Valbenazine API Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Tetrabenazine Tablets Market Research Report 2024
Global Valsartan API Market Research Report 2025
Flumazenil API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ranolazine API Market Research Report 2025
Global Rifaximin API Market Research Report 2024
Global Bisbentiamine Market Research Report 2025
Global Fenbendazole API Market Research Report 2025
Albendazole API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cinnarizine API Market Research Report 2025
Global Benzbromarone API Market Research Report 2025
Global Flumazenil Market Research Report 2024
Global Pregabalin API Market Research Report 2025
Global Nadroparin Calcium API Market Research Report 2025
Mebendazole API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global API Drug Development Service Market Research Report 2024
Global Phenylbutazone API Market Research Report 2024
Global Prilocaine API Market Research Report 2025
Global N N Di 1 naphthyl 4 4 benzidine Market Research Report 2024
Global Bezoar API Market Research Report 2024
Global Phenothiazine Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions